Centessa Pharmaceuticals plc American Depositary Shares
CNTANASDAQHealthcare · Pharmaceutical Preparations
Market cap
$6.12B
Employees
129
Exchange
NASDAQ
Headquarters
ALTRINCHAM, CHESHIRE, X0
About Centessa Pharmaceuticals plc American Depositary Shares
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.